Optimize your hereditary angioedema (HAE) care management with the help of an allergist-immunologist, PCP, gastroenterologist ...

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that the first patient has been dosed in the Aurora study (NCT07157254) evaluating the efficacy and safety of GTX-102 (apazunersen), an ...